UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 31, 2024 5:00 P.M.
Form:
S-3
CIK:
0001610820
Company Name:
BriaCell Therapeutics Corp.
File Number:
333-276650